Plain Language Summary
AMLhaematologyplain language
Plain Language Summary: A Study of Venetoclax Plus Azacitidine in Older Adults with Acute Myeloid Leukaemia (AML)
A patient-facing plain language summary of the VIALE-A phase III trial, written to EUPATI standards for adults with AML who are not able to have intensive chemotherapy. Approved for publication on the trial sponsor's patient portal.